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Single nucleotide polymorphism (SNPS) analysis of Mu-opioid receptors (OPRM1) 
using denaturing high performance liquid chromatography (DHPLC) among the 
intravenous drug users 
 
ABSTRACT 
Objectives: The genetic polymorphisms of OPRM1 among the intravenous drug users 
(IVDUs) and healthy controls were investigated and the risk of addiction in relation to 
OPRM1 was predicted. Methods: PCR-denaturing high performance liquid chromatography 
(DHPLC) method was developed to investigate SNPs in the coding regions of OPRM1 in 93 
IVDUs and 100 healthy controls. Subjects were confirmed to be drug addicts and their 
personality was studied using validated Tridimensional Personality Questionnaires (TPQ). 
Results: Based on the results obtained, seven SNPs were detected; two of them were 
previously associated with addiction. Homozygous OPRM1:c.118GG and heterozygous 
OPRM1:c.118AG variants were found to have higher frequencies among the IVDUs and 
healthy controls. In addition, carriers of OPRM1:c.118G allele scored higher for novelty 
seeking (NS) and harm avoidance (HA) with more explorative, neurotic and uninhibited 
personalities. We identified a new variant of OPRM1:c.77C>G which is located at the N-
terminus of the G-coupled protein receptor and possibly decreases the binding affinity of its 
ligands among the IVDUs. Conclusion: In conclusion, DHPLC allows the detection of new 
and existing variants of OPRM1. Genotyping of OPRM1:c.118A>G and assessment of 
personalities using TPQ provide valuable tools for determination of addiction risk. 
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